You are here

Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars From Prior Breast Surgery

Last updated on August 9, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Pasadena, California, 91105 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Reduction in Hypertrophic Skin Scarring
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-65 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Subjects must have previous had breast surgery resulting in unacceptable scars.

- Subject has chosen to have breast scars revised.

- Subject must not be pregnant or lactating.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Currently pregnant or pregnant during the 6 months, prior to inclusion in the study or
lactating.

- Participation in another clinical trial within 30 days prior to the start of the
study.

- Any other condition or prior therapy, which, in the opinion of the PI, would make the
subject unsuitable for the study.

NCT01346969
Pfizer
Completed
Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars From Prior Breast Surgery

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now